Australian Cannabis Producers Eye European Market, Especially Germany And France, Marijuana And Menstrual Pain Study Underway
Australian Cannabis Producers Eye European Market, Especially Germany And France, Marijuana And Menstrual Pain Study Underway
澳大利亚大麻股生产商瞄准欧洲市场，特别是德国和法国，正在进行大麻和经期疼痛的研究
As the European cannabis scene develops, cannabis growers in Australia are looking to seize the opportunity. Some Australian farmers are already signing multi-million dollar export deals.
随着欧洲大麻行业的发展，澳洲的大麻种植者也在寻求抓住这个机会。一些澳大利亚的农民已经签署了数百万美元的出口协议。
Australian Natural Therapeutics Group (ANTG) is focusing on Germany, which recently relaxed its cannabis laws. Among the most significant reforms is the regulation of medical marijuana similar to ibuprofen. ANTG has been exporting to Germany since 2020.
澳大利亚天然治疗集团（ANTG）正在专注于德国市场，该市场最近放宽了其大麻法规。其中最重要的改革是对医用大麻的监管类似于布洛芬，自2020年以来，ANTG已开始向德国出口。
Germany is considered a leader of the European medical marijuana market, accounting for $621 million of the total $821 million sales in 2023, writes ABC news.
据ABC资讯报道，德国被认为是欧洲医用大麻市场的领军者，在2023总销售额的8210万美元中占据了6210万美元。
"Germany is definitely the key market with a 90 million-odd population and a fairly...
ANTG首席执行官马特·坎特...
登录免费看全文
登录/注册